Acta Med. 2010, 53: 3-11
https://doi.org/10.14712/18059694.2016.56
Non-steroidal Anti-inflammatory Drug Induced Injury to the Small Intestine
References
1. GA, Polhamus CD, Muskat P, et al: Diaphragm-like strictures of the ileum associated with NSAID use: a rare complication. South Med J 1998; 91:395–7.
<https://doi.org/10.1097/00007611-199804000-00018>
2. KK, Petros JG, Cave DR, et al: Use of intraoperative enteroscopy to diagnose nonsteroidal anti-inflammatory drug injury to the small intestine. Gastrointest Endosc 1999; 49: 544–6.
<https://doi.org/10.1016/S0016-5107(99)70063-5>
3. PA, Agrawal D, Cantero D, et al: Spiral enteroscopy with the new DSB overtube: a novel technique for deep peroral small-bowel intubation. Endoscopy 2008; 40:974–8.
<https://doi.org/10.1055/s-0028-1103402>
4. MC, Howatson AG, Torrance CJ: Gastrointestinal damage associated with the use of nonteroidal antiinflammatory drugs. N Engl J Med 1992; 327:751–754. PMID: 1501650.
<https://doi.org/10.1056/NEJM199209103271101>
5. JT, Clark R, Walker MW, et al: New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26:93–9.
<https://doi.org/10.1038/sj.jp.7211429>
6. RF, Alvarez Perez JA, Garcia Bear I, et al: [Indomethacininduced ileal perforation]. Gastroenterol Hepatol 2004; 27: 18–20.
<https://doi.org/10.1016/S0210-5705(03)70439-7>
7. I, Zanelli G, Prouse P, et al: Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987; 2:711–4.
<https://doi.org/10.1016/S0140-6736(87)91075-0>
8. I, Zanelli G, Smith T, et al: Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93:480–9.
<https://doi.org/10.1016/0016-5085(87)90909-7>
9. I, Zanelli G, Smith T, et al: The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol Suppl 1987;64:55–62.
<https://doi.org/10.3109/03009748709096722>
10. I, Williams P, Smethurst P, et al: Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986;27:1292–7.
<https://doi.org/10.1136/gut.27.11.1292>
<PubMed>
11. I, Zanelli G, Prouse P, et al: Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs 1986;32 Suppl 1:35–41.
<https://doi.org/10.2165/00003495-198600321-00007>
12. I, Williams P, So A, et al: Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171–4.
<https://doi.org/10.1016/S0140-6736(84)92739-9>
13. I, Smethurst P, Price A: Metronidazole reducess intestinal inflammation and blood loss in NSAID induced enteropathy. Gut 1992;33:1204–08.
<https://doi.org/10.1136/gut.33.9.1204>
<PubMed>
14. I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832–47.
<https://doi.org/10.1016/0016-5085(93)90667-2>
15. Bures J, Rejchrt S. Small Bowel Investigation and Atlas of Enteroscopy. Grada Publishing 2001.
16. SA, Liu Z, Ceuppens J. et al. Comparative study on the in vivo efficacy of metronidazole, aztreonam and amoxycillin/clavulanic acid in the indomethacin model: evidence for immuno-modulatory properties of metronidazole. Gastroenterology 2001;118(suppl2):A572.
<https://doi.org/10.1016/S0016-5085(00)84424-8>
17. GR, Wilkie ME, Rampton DS: Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability. Dig Dis Sci 1993; 38:417–25.
<https://doi.org/10.1007/BF01316493>
18. NM, Jamali F: Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scarvengers. Hum Exp Toxicol 1997;16:345–9.
<https://doi.org/10.1177/096032719701600701>
19. NM, Roseth AG, Appleyard CB, et al: NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther 1997; 11:69–79.
<https://doi.org/10.1046/j.1365-2036.1997.115286000.x>
20. NM, Saleh JY, Skjodt NM: Detection and prevention of NSAID-induced enteropathy. J Pharm Pharm Sci 2000;3:137–55.
21. EJ, Dohrman AJ, Romero JJ, et al: Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J Pharm Pharmacol 2005;57: 93–9.
<https://doi.org/10.1211/0022357055191>
22. AH, Lintott GAM: Gastroscopic observation of effect of aspirin and certain other substances on stomach. Lancet 1938;2:1222–25.
<https://doi.org/10.1016/S0140-6736(00)78970-7>
23. H, Hosono K, Inamori M, et al: Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009;79:44–51.
<https://doi.org/10.1159/000204465>
24. S, Distrutti E, Cirino G, et al: The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 2006;131:259–71.
<https://doi.org/10.1053/j.gastro.2006.02.033>
25. PJ, Hawkey CJ: Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 2005;21:169–75.
<https://doi.org/10.1097/01.mog.0000153314.51198.58>
26. HJ: Sulindac-associated small bowel lesion. J Clin Gastroenterol 1986; 8:569–71.
<https://doi.org/10.1097/00004836-198610000-00017>
27. S, Seo T, Gudis K, et al: Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009;69: 1339–46.
<https://doi.org/10.1016/j.gie.2008.08.017>
28. G, Delvaux M, Frederic M: Capsule endoscopy in non-steroidal anti-inflammatory drugs-enteropathy and miscellaneous, rare intestinal diseases. World J Gastroenterol 2008;14:5237–44.
<https://doi.org/10.3748/wjg.14.5237>
<PubMed>
29. JL, Eisen GM, Lewis B, et al: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005;3:133–41.
<https://doi.org/10.1016/S1542-3565(04)00619-6>
30. JL, Eisen GM, Lewis B, et al: Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007; 25:1211–22.
<https://doi.org/10.1111/j.1365-2036.2007.03312.x>
31. M, Cruchet S, Verbeke S: Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Aliment Pharmacol Ther 2001;15:11–7.
<https://doi.org/10.1046/j.1365-2036.2001.00898.x>
32. DY, Opekun AR, Willingham FF, et al: Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55–9.
<https://doi.org/10.1016/S1542-3565(04)00603-2>
33. M, Kataoka K, Arimochi H, et al: Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug. World J Gastroenterol 2005;11:1040–3.
<https://doi.org/10.3748/wjg.v11.i7.1040>
<PubMed>
34. M, Kataoka K, Arimochi H, et al: Role of unbalanced growth of gramnegative bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. J Med Invest 2004;51:43–51.
<https://doi.org/10.2152/jmi.51.43>
35. CJ: NSAIDs, coxibs, and the intestine. J Cardiovasc Pharmacol 2006;47 Suppl 1:S72–5.
<https://doi.org/10.1097/00005344-200605001-00013>
36. Hawkey CJ, Ell C, Simon Beal: Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole. Clin Gastroenterol Hepatol 2008;536.
37. J, Smith T, Macpherson A, et al: Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum 1994;37: 1146–50.
<https://doi.org/10.1002/art.1780370806>
38. J, Smith T, Macpherson A, et al: Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum 1994;37:1146–50.
<https://doi.org/10.1002/art.1780370806>
39. Y, Yamamoto H, Kita H, et al: Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol 2005;11:4861–4.
<https://doi.org/10.3748/wjg.v11.i31.4861>
<PubMed>
40. JA, Masip MC, Alomar A, et al: Localized intestinal perforation after intravenous indomethacin in a premature infant. Helv Paediatr Acta 1986;41: 437–40.
41. K, Umegaki E, Watanabe T, et al: Present status and strategy of NSAIDsinduced small bowel injury. J Gastroenterol 2009;44:879–88.
<https://doi.org/10.1007/s00535-009-0102-2>
42. K, Matsumoto T, Kuroki F, et al: Protective effect of lactosucrose on intracolonic indomethacin-induced small-intestinal ulcers in rats. Scand J Gastroenterol 1999;34:264–9.
43. CM, Walley MJM, Simpson J, et al: COX-1, COX-2 and the topical effect in NSAID-induced enteropathy. Inflammopharmacology 2003;11: 363–270.
<https://doi.org/10.1163/156856003322699546>
44. G, Meron G, Glukhovsky A, et al: Wireless capsule endoscopy. Nature 2000;405:417.
<https://doi.org/10.1038/35013140>
45. PE, Sladen GE, Filipe I: Mefenamic acid enteropathy. J Clin Pathol 1987; 40:1221–7.
<https://doi.org/10.1136/jcp.40.10.1221>
<PubMed>
46. M, Foster R, Sigthorsson G, et al: Role of bile in pathogenesis of indomethacin- induced enteropathy. Arch Toxicol 2007;81:291–8.
<https://doi.org/10.1007/s00204-006-0149-2>
47. Y, Iwamoto M, Nara H, et al: A case of rheumatoid arthritis with protein losing enteropathy induced by multiple diaphragmatic strictures of the small intestine: successful treatment by bougieing under double-balloon enteroscopy. Gut 2006;55:1372.
<https://doi.org/10.1136/gut.2006.100446>
<PubMed>
48. R, Geier MS, Butler RN, et al: Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy. Dig Dis Sci 2007;52:1247–52.
<https://doi.org/10.1007/s10620-006-9443-3>
49. S, Nishio H, Ogura M, et al: Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression. J Pharmacol Sci 2007;103:40–7.
<https://doi.org/10.1254/jphs.FP0061181>
50. H, Yamamoto H: Double-balloon endoscopy for the diagnosis and treatment of small intestinal disease. Best Pract Res Clin Gastroent 2006;20:179–94.
<https://doi.org/10.1016/j.bpg.2005.09.004>
51. M, Bureš J, Vykouřil, et al: Intraopeartive enteroscopy Ten years experience at a single tertiary center. Surg Endosc 2007;1111–16.
<https://doi.org/10.1007/s00464-006-9052-4>
52. M, Yoshida N, Ichikawa H, et al: Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006; 17:89–93.
53. A, Scarpignato C: Microbial flora in NSAIDinduced intestinal damage: a role for antibiotics? Digestion 2006;73(Suppl 1):13650.
<https://doi.org/10.1159/000089789>
54. L, Curtis SP, Langman M, et al: Lower gastrointestinal events in a doubleblind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008;135: 1517–25.
<https://doi.org/10.1053/j.gastro.2008.07.067>
55. L, Smith R, Min K, et al: Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006;24:751–67.
<https://doi.org/10.1111/j.1365-2036.2006.03043.x>
56. J, Price AB, Levi AJ, et al: Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol 1988;41:516–26.
<https://doi.org/10.1136/jcp.41.5.516>
<PubMed>
57. MJ, Morgan L, Worrall A: Use of antinflammatory drugs by patients admitted with small or large bowel perforatons and haemorhage. Br Med J 1985;290:347–349.
<https://doi.org/10.1136/bmj.290.6465.347>
<PubMed>
58. AZA, Sipahi AM, Damiao AOMC, et al: Protective effect of metronidazole on uncoupling NSAID: a new mechanism mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 2001;48:163–7.
<https://doi.org/10.1136/gut.48.2.163>
<PubMed>
59. L, Thjodleifsson B, Seigal A, et al: Long-term effects of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007; 5:1040–5.
<https://doi.org/10.1016/j.cgh.2007.04.031>
60. T, Kudo T, Esaki M, et al: Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008;43:490–6.
<https://doi.org/10.1080/00365520701794121>
61. TR, Aabakken L, Roseth A, et al: Faecal calprotectin shedding after shortterm treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31:339–44.
<https://doi.org/10.3109/00365529609006407>
62. AJ, McKenzie JF: Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992;33:887–889.
<https://doi.org/10.1136/gut.33.7.887>
<PubMed>
63. AJ, Mokhashi M, Straiton M, et al: Push enteroscopy and heater probe therapy for small bowel bleeding. Gastrointest Endosc 1996;44:394–7.
<https://doi.org/10.1016/S0016-5107(96)70087-1>
64. AJ, McKenzie JF: Small bowel enteroscopy and NSAID ulcerations. Lancet 1991;337:1550.
<https://doi.org/10.1016/0140-6736(91)93245-5>
65. HS, Sandhu AS, Cook LN, et al: Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg 1981; 16:1003–7.
<https://doi.org/10.1016/S0022-3468(81)80865-2>
66. Y, Nakamura M, Ohmiya N, et al: Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008;43:270–6.
<https://doi.org/10.1007/s00535-007-2155-4>
67. M, James S, Meakin S, et al: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329: 15–9.
<https://doi.org/10.1136/bmj.329.7456.15>
<PubMed>
68. S, Kopáčová M, Tachecí I, et al: Retrieval of retained wireless capsule endoscope from the ileum by means of push-and-pull enteroscopy using the doubleballoon technique (double-balloon enteroscopy) in a patient with Crohn’s disease. Folia Gastroenterol Hepatol 2006;4:33–37.
69. BK, Davies NM, Wallace JL: Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 1997;112:109–17.
<https://doi.org/10.1016/S0016-5085(97)70225-7>
70. A, Asano T: Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977;14:333–41.
<https://doi.org/10.1016/0090-6980(77)90178-2>
71. H, Kjellander J, Sundberg-Gilla Beal: In vitro effects of sulphasalazine, azodisal sodium, and their metabolites on Clostridium difficile and some other faecal bacteria. Scand J Gastroenterol 1985;20:607–12.
<https://doi.org/10.3109/00365528509089704>
72. FJ, Heiss FW, Roberts PL: Diaphragm like strictures of the small bowel associated with use of nonsteroidal antiinflammatory drugs. Am J Roentgenol 1994; 162:49–50.
<https://doi.org/10.2214/ajr.162.1.8273688>
73. R, Sanders DS, McAlindon ME, et al: Capsule endoscopy for the evaluation of nonsteroidal anti-inflammatory drug-induced enteropathy: United Kingdom pilot data. Gastrointest Endosc 2006;64:1035.
<https://doi.org/10.1016/j.gie.2006.07.007>
74. G, Tibble J, Hayllar J, et al: Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998;43:506–11.
<https://doi.org/10.1136/gut.43.4.506>
<PubMed>
75. G, Rosen Ramey D: NSAID induced gastrointestinal complications: the ARAMIS perspective—1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998;51:8–16.
76. G, Simpson RJ, Walley Meal: COX-1 and 2, intestinal integrity and pathogenesis of NSAID-enteropathy in mice. Gastroenterology 2002;122: 1913–23.
<https://doi.org/10.1053/gast.2002.33647>
77. S, Tibble J, Sigthorsson G, et al: Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol 2001;15:723–38.
<https://doi.org/10.1053/bega.2001.0231>
78. E, Bai JC, Sugai E, et al: Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs. Gut 2001;49:650–5.
<https://doi.org/10.1136/gut.49.5.650>
<PubMed>
79. S, Sigthorsson G, Simpson RJ, et al: Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000;14:639–50.
<https://doi.org/10.1046/j.1365-2036.2000.00723.x>
80. HF, Krone CL: Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy. Am J Gastroentorol 1973;59:162–9.
81. S, Watanabe T, Tabuchi M, et al: Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008;78:208–13.
<https://doi.org/10.1159/000190403>
82. Tacheci, I a kolektiv. Kapslová endoskopie. 2008. Hradec Králové, Nucleus HK.
83. JA, Sigthorsson G, Foster R, et al: High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362–6.
<https://doi.org/10.1136/gut.45.3.362>
<PubMed>
84. T, Saitoh Y, Andoh A, et al: Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences. Endoscopy 2008;40:11–5.
<https://doi.org/10.1055/s-2007-966976>
85. JL, Reuter BK, Cirino G: Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J Gastroenterol Hepatol 1994;9 Suppl 1:S40–4.
<https://doi.org/10.1111/j.1440-1746.1994.tb01300.x>
86. JL, Del Soldato P: The therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol 2003;17:11–20.
<https://doi.org/10.1046/j.1472-8206.2003.00125.x>
87. T, Sugimori S, Kameda N, et al: Small bowel injury by low-dose enteric- coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6:1279–82.
<https://doi.org/10.1016/j.cgh.2008.06.021>
88. T, Higuchi K, Kobata Aeal: Nonsteroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008;57:181–187.
<https://doi.org/10.1136/gut.2007.125963>
89. BJ, Laszlo F, Evans SM, et al: Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995;116:2286–90.
<https://doi.org/10.1111/j.1476-5381.1995.tb15066.x>
<PubMed>
90. BJ: Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol 2004;500:427–39.
<https://doi.org/10.1016/j.ejphar.2004.07.042>
91. Wong Kee Song LM, Marcon NE: NSAIDs: Adverse effects on the distal small bowel and colon. UpToDate, Wellesley, 2009; vol 17.1. www.uptodate.com.
92. T, Deitch E, Specian RD eal: Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641–62.
<https://doi.org/10.1007/BF00920471>
93. HH, Chen YY, Soon MS: Nonsteroidal anti-inflammatory drug-associated ileal ulcers: an evaluation by double-balloon enteroscopy. Gastrointest Endosc 2006;63:328; discussion 328.
<https://doi.org/10.1016/j.gie.2005.06.063>
94. MM, De Petris G, Leighton JA, et al: Diaphragm disease after use of nonsteroidal anti-inflammatory agents: first report of diagnosis with capsule endoscopy. J Clin Gastroenterol 2004;38:686–91.
<https://doi.org/10.1097/01.mcg.0000135367.66159.87>
